European Research Infrastructure for Imaging Technologies in Biological and Medical Sciences (EuBI-ERIC)
26 April 2021
Modified: 26 April 2021
Reading time: 2 minute(s)
Provides open physical access to a wide range of world-class biological and biomedical imaging technologies for researchers in life sciences.
It aims to organize a network of microscopic and medical imaging laboratory services, and make costly and expertise-intensive methods available in Europe.
| Short name | EuBI-ERIC |
| Name | The European Research Infrastructure for Imaging Technologies in Biological and Biomedical Sciences |
| Official website | http://www.eurobioimaging.eu/ |
| Year of foundation | 2010 (operational phase: from 2019) |
| ESFRI project/landmark | landmark |
| Headquarters | Heidelberg, Germany |
| Number of member countries | 14 |
| Participating countries | Members: Austria, Bulgaria, Czech Republic, Denmark, Finland, France, Hungary, Israel, Italy, Netherlands, Norway, Portugal, Sweden, UK, + European Molecular & Biology Laboratory (EMBL) Observers: Belgium |
| Hungary’s accession | 2016 |
| Partner institutions in Hungary |
University of Debrecen Biological Research Centre, Szeged, Semmelweis University, Femtonics Kft. University of Pécs, Szentágothai Research Centre |
| Public administration representative |
Klára Horváth National Research, Development and Innovation Office Department of International Affairs 1077 Budapest, Kéthly Anna tér 1. Phone: +36 1 896 3748 Email: klara.horvath@nkfih.gov.hu |
| Professional representative |
János Szöllősi professor, academician University of Debrecen, ÁOK, Department of Biophysics and Cell Biology György Vámosi senior research fellow University of Debrecen, ÁOK, Department of Biophysics and Cell Biology |
| Membership payments | 2015: - 2016: - 2017: EUR 0 2018: EUR 0 2019: EUR 0 2020: EUR 21,627.21 (≈ HUF 7.8 million) |
Benefits of the membership for Hungary
- Research results increase our understanding of various diseases, from diagnosis to treatment, improving the general health of the population.
- Gives access for the Hungarian research community to laboratories equipped with the most advanced technologies.
- The portfolio of services provided to pharmaceutical development and biotech companies is extended with new bioimaging technologies introduced based on the experience gained in foreign “Node” status institutions, which increases the R&D performance and the efficiency of companies.
- From 2018, Hungary connects to the international infrastructure through the Cellular Imaging Hungary consortium, which comprises several Hungarian “Node” status institutions.
Updated: 26 April 2021